COLUMBIA, Md.--Martek Biosciences and the Carnegie Institution of Washington were awarded a US patent for methods invented jointly by their scientists for introducing DNA into algae.

MAYNARD, Mass.--Exact Laboratories here has received a US patent for methods for analyzing genetic variations, such as single nucleotide polymorphisms, for pharmaco-genomics and genetics re

SANTA FE, NM--The National Center for Genome Resources and the Samuel Roberts Noble Foundation have released new expressed sequence tag data from a collaboration studying model plant

ST.

GAITHERSBURG, Md.--NeuralStem BioPharmaceuticals is the fourth customer to purchase a module of Gene Logic's GeneExpress database.

RESEARCH TRIANGLE PARK, NC--Paradigm Genetics announced that it has delivered more screening targets to Bayer in accordance with a research collaboration aimed at developing herbicid

SAN DIEGO--Through an expanded licensing agreement, Aurora Biosciences will provide additional assay development and screening of a group of G-protein-coupled receptors isolated by Merck

NEW HAVEN, Conn.--CuraGen and Genentech announced that their drug research collaboration will continue for at least two-and-a-half-years.

WALNUT CREEK, Calif.--Researchers at the Department of Energy's Joint Genome Institute here have completed working drafts of the DNA sequence of human chromosomes 5, 16, and 19.

BETHESDA, Md.--The US National Institutes of Health awarded $12.8 million to investigators at nine projects that will contribute to the creation of a public pharmacogenetics database.

OXFORD, UK--Affymetrix lost the first round of a DNA microarray patent and licensing dispute here when a court ruled in favor of Oxford Gene Technology.

TOKYO--Attendees of the Fourth Annual International Conference on Computational Molecular Biology, also known as Recomb 2000, held here April 7-11, were sent home with the challenge to find new routes for bridging experimental biology with computational and technological advances.

BERKELEY, Calif.--Using a pair of radical bioinformatics strategies for headlights, a team of university and private-sector researchers have peered into the dark terrain of the Mycobacterium tuberculosis genome and identified a host of potential drug targets.

ROCKVILLE, Md.--Two functional genomics and drug discovery patents have been issued to Massachusetts General Hospital and exclusively licensed to Life Technologies here.

EXTON, Pa.--3-Dimensional Pharmaceuticals has received its second patent on a method for getting quantitative measurements of drug-binding affinity to almost any protein or nucleic acid target--a technology the

MAYNARD, Mass.--Exact Laboratories has been issued its seventh US patent, titled "Methods for the Detection of Loss of Heterozygosity," which describes methods for analyzing genetic variations, such as single-nu

GAITHERSBURG, Md.--Digene has received approval from the US Food and Drug Administration to manufacture and distribute products of its Hybrid Capture Gene Analysis System at the company's new manufacturing, rese

HAYWARD, Calif.--Aventis CropScience of Lyon, France, has renewed its nonexclusive access to Lynx Therapeutics' genomics discovery services, limited to the agricultural field, for an additional year.

ROCKVILLE, Md.--Celera Genomics has signed an agreement with Takeda Chemical Industries of Osaka, Japan, that provides a five-year comprehensive subscription to five Celera databases, including its bioinf

LOS ANGELES--Protein Pathways received a $100,000 SBIR phase I grant from the US National Institutes of Health to assign functions, using computational methods, to more than 1,500 genes from the Mycoba

CAMBRIDGE, Mass.--Lion Bioscience last week celebrated the opening of its American subsidiary here, in offices next door to the Lion Bioscience Research, which was established in June last year to serve L

SAN DIEGO--Industrial genomics company Sequenom announced last week that it reached a collaborative and a commercial agreement with Methexis Genomics of Ghent, Belgium.

KYOTO, Japan--Takara Shuzo, a large liquor and seasonings company here that also has a biotechnology division, said it will form a genomics unit called Dragon Genomics, Bloomberg reported.

CAMBRIDGE, UK--Gemini Genomics, formerly Gemini Holdings, announced that it has entered into a two-year drug target identification collaboration with CuraGen to accelerate drug discovery.

WASHINGTON--Nature published a letter from James Decker of the US Department of Energy's Office of Science that stated that the US DOE is still involved in the human genome effort.